Retracted: Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.
作者信息
International BioMed Research
出版信息
Biomed Res Int. 2024 Jan 9;2024:9874310. doi: 10.1155/2024/9874310. eCollection 2024.
Abstract
[This retracts the article DOI: 10.1155/2022/7145606.].
摘要
相似文献
1
Retracted: Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.
Biomed Res Int. 2024 Jan 9;2024:9874310. doi: 10.1155/2024/9874310. eCollection 2024.
2
Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.
Biomed Res Int. 2022 Jun 8;2022:7145606. doi: 10.1155/2022/7145606. eCollection 2022.
3
Retracted: Effects of Anesthetics on Proliferation and Apoptosis of Drug-Resistant Human Colon Cancer Cells.
Biomed Res Int. 2023 Jul 12;2023:9767182. doi: 10.1155/2023/9767182. eCollection 2023.
4
Retracted: Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells.
Biomed Res Int. 2024 Jan 9;2024:9798548. doi: 10.1155/2024/9798548. eCollection 2024.
5
Retracted: To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.
J Healthc Eng. 2023 Aug 23;2023:9896408. doi: 10.1155/2023/9896408. eCollection 2023.
6
Retracted: Study on the Mechanism of Xiaotan Sanjie Recipe in the Treatment of Colon Cancer Based on Network Pharmacology.
Biomed Res Int. 2023 Oct 4;2023:9897128. doi: 10.1155/2023/9897128. eCollection 2023.
7
Retracted: Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis.
Biomed Res Int. 2023 Oct 4;2023:9830710. doi: 10.1155/2023/9830710. eCollection 2023.
8
Retracted: Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer.
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9817296. doi: 10.1155/2023/9817296. eCollection 2023.
9
Retracted: Efficacy and Safety of Radical Resection of Rectal Combined with Selective Lateral Lymph Node Dissection in the Treatment of Low Rectal under Meta-analysis.
Contrast Media Mol Imaging. 2023 Jul 19;2023:9813132. doi: 10.1155/2023/9813132. eCollection 2023.
10
Retracted: Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9842016. doi: 10.1155/2023/9842016. eCollection 2023.
本文引用的文献
1
Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.
Biomed Res Int. 2022 Jun 8;2022:7145606. doi: 10.1155/2022/7145606. eCollection 2022.
Zotero 插件